In this 2-year study, the suitability of the Hsd:Sprague-Dawley SD (SD) as a replacement for the Cri:CD BR (CD) rat was assessed by comparing survival rates, palpable mass incidence, body weights, food consumption, clinical laboratory parameters, and necropsy and histopathology observations. At Week 104, survival rates in the CD and SD males were 29 and 49%, respectively. Corresponding survival rates in females were 44 and 63%. The total numbers of animals with palpable masses and animals with neoplasms were similar in the CD and SD rats; however, the total numbers of palpable masses and neoplasms were higher in the CD rats. The incidence of cornea! lesions was higher in the SD rats, whereas the incidence of lenticular opacities was higher in the CD rats. Body weights, food and water consumption, and organ weights were significantly lower in the SD rats. In contrast, food intake per kilogram of body weight was slightly higher in the SD rats. Numerous differences in clinical laboratory parameters between the CD and SD rats were observed. Some of these were consistent with the increased prevalence of kidney disease and secondary sequelae in the SD rats. Taken together, the better survival, smaller size, and lower food consumption of the SD rat may make it a better model for chronic bioassays. However, the increased propensity for spontaneous renal disease may limit the utility of the SD rat for studying nephrotoxic compounds, c 1996 sodtty of Toxicology In recent years, there has been growing concern in the toxicology community over the decreased life span seen in the CD rat (Lang, 1991) . In the United States and other countries, this stock of rats is widely used in chronic toxicity and oncogenicity bioassays in the pharmaceutical, chemical, and pesticide industries. In chronic toxicity and oncogenicity bioassays, many regulatory guidelines specify that survival of at least 50% or 25 rats per sex per dose be achieved at the termination of the study (2 years). When survival falls below these levels, the objectives of the study may be jeopardized by the reduction in statistical power associated with excessive premature deaths and the confounding effects of age-associated pathology. Consequently, the shortened life span of the CD rat has raised questions as to its suitability for chronic toxicity and oncogenicity bioassays.
1 Presented in part at the 33rd and 35th Annual Meetings of the Society of Toxicology, Dallas, TX, March 1994, and Anaheim, CA, March 1996. 2 To whom correspondence should be addressed at Central Research Division, Pfizer Inc., Eastern Point Road, Groton, CT 06340. Fax: (860) In recent years, there has been growing concern in the toxicology community over the decreased life span seen in the CD rat (Lang, 1991) . In the United States and other countries, this stock of rats is widely used in chronic toxicity and oncogenicity bioassays in the pharmaceutical, chemical, and pesticide industries. In chronic toxicity and oncogenicity bioassays, many regulatory guidelines specify that survival of at least 50% or 25 rats per sex per dose be achieved at the termination of the study (2 years). When survival falls below these levels, the objectives of the study may be jeopardized by the reduction in statistical power associated with excessive premature deaths and the confounding effects of age-associated pathology. Consequently, the shortened life span of the CD rat has raised questions as to its suitability for chronic toxicity and oncogenicity bioassays.
Some possible solutions to this problem include switching to an alternative strain or stock of rat, increasing the number of animals on study, shortening the length of the study from 24 months, modifying the nutritional content of the diet, and restricting feed access (Lang, 1991) . It has been reported that concomitant with the increased body weight seen in the CD rat in recent years were an increase in age-associated diseases and a decrease in survival (Hart et ai, 1995) . In this study, we evaluated the suitability of the SD as a replacement for the CD rat in the 2-year bioassay. The CD rat was derived from the SD rat several decades ago (Lang and White, 1994) . Thus, we chose this stock of rat as a potential replacement for the CD rat since these rats share a common ancestry and the SD rat has been reported by the breeder to weigh less than the CD rat at an equivalent age. Therefore, these commonly used stocks of laboratory rats may share many of the same characteristics, but survival may be better in the SD rat.
The objective of this study was to assess the suitability of the SD as a replacement for the CD rat in chronic toxicity and oncogenicity bioassays by comparing the life span, palpable mass incidence, body weight gain pattern, food consumption pattern, clinical laboratory parameters, organ weights, necropsy observations, and histopathology (nonneoplastic and neoplastic) findings in these rats. This study also enabled us to gain experience with and establish a historical control data base for the SD rat.
MATERIALS AND METHODS
Test animals. CrhCD BR rats were obtained from Charles River Laboratories (Raleigh, NC), and Hsd:Sprague-Dawley SD rats were obtained from Harlan Sprague Dawley (Frederick, MD). The animals were 4 weeks old upon receipt and were acclimated for 2 weeks. The rats were housed individually in suspended polycarbonate cages measuring approximately 19 X 21 X 20 cm each. Hardwood chips were used as bedding material. Cages, racks, and feeders were changed weekly. The facility's HVAC system provided at least 15 air changes per hour and maintained the temperature between 19 and 24°C and the relative humidity between 40 and 60%. Fluorescent lighting was provided on a 12-hr on/off cycle (lights on 6:00 AM, EST). Rats were fed Purina Certified Rodent Chow 5002 ground meal ad libitum. Water from die local municipal water supply was provided ad libitum by an automatic watering system or water bottles. Each rat was individually identified with a permanent animal number by tail tattoo.
Experimental design. The study was initiated with groups of 60 rats/ stock/sex. Ten rats/stock/sex were terminated after 1 year for interim evaluation. The remaining 50 rats/stock/sex were allocated for die full 2 years of the study. Clinical signs, body weight, food consumption, and mortality were monitored throughout the study. Clinical laboratory tests were conducted at 3, 6, 12, 18, and 24 months.
In-life observations. All animals were observed at least twice daily (AM and PM) for general appearance, behavior, signs of morbidity, and mortality. Each week, all animals were given a detailed physical examination dial included palpation for the presence of tissue masses. Ophnialmoscopic examinations were performed pretest (only normal animals were assigned to the study) and prior to scheduled terminations. Individual body weights and food and water consumption were determined weekly for the first 13 weeks and at least every 4 weeks thereafter.
Clinical laboratory tests. The first 20 available animals/group were utilized for clinical laboratory tests. Blood samples were drawn in a fasted state from die orbital plexus (3, 6, 9, and 18 months) under methoxyflurane anesthesia or from the abdominal aorta (24 months) under sodium pentobarbital anesthesia. Urine samples were collected overnight in metabolism cages. Automated hematology parameters were measured with an ORTHO ELT-8/ds hematology analyzer (Ortho Diagnostic Systems, Inc., Westwood, MA) and included hematocrit (HCT), hemoglobin (HGB), red blood cell count (RBC), total white blood cell count (WBC), platelet count (PLT), mean corpuscular volume (MC V), mean corpuscular hemoglobin concentration (MCHC), and mean corpuscular hemoglobin (MCH). Manually measured parameters included differential WBC and reticulocyte (if HCT was <37%) counts. Prothrombin time (PT) was measured widi a COAG-A-MATE X • 2 (General Diagnostics, Morris Plains, NJ). Clinical chemistry parameters were assayed with an IL MONARCH 2000 Chemistry System (Instrumentation Laboratory, Lexington, MA) and these included alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALK PHOS), 5' nucleotidase (5' NUCLEO), sorbitol dehydrogenase (SDH), gamma glutamyl transferase (GGT), total protein, albumin, globulin, albumin/globulin ratio (A/G), cholesterol, total bilirubin (T BILI), direct bilirubin (measured when T BILI was >0.4 mg/dl), glucose, triglycerides, blood urea nitrogen (BUN), creatinine, sodium, potassium, chloride, calcium, inorganic phosphorus (PHOS), and creatine kinase (CK). Automated urinalysis parameters, including pH, protein, glucose, ketones, occult blood, urobilinogen, and bilirubin, were determined with an AMES CLIN1-TEK 10 (Miles Diagnostic Division, Elkhart, IN) urine chemistry analyzer. Other parameters, including appearance, volume, specific gravity, and microscopic examination of sediment, were determined manually.
Postmortem examination.
Rats were fasted overnight prior to scheduled termination. They were anesthetized with sodium pentobarbital (ip) and terminated by exsanguination via die abdominal aorta. All animals were necropsied. Liver, testes (without epididymides), kidneys, ovaries, brain, Grade 5: Severe. Included histopathologic change that is an overwhelming feature of the tissue.
For each nonneoplastic lesion, weighted grades were calculated by multiplying the severity grade by the number of animals with that grade and dividing by the number of animals with that particular lesion.
Neoplastic lesions were characterized as benign or malignant. Malignant neoplasms were further characterized as primary or secondary (metastatic). Multicentric neoplasms were treated as primary in each site.
Statistical analysis. Quantitative continuous data such as body weight, food consumption, and feed efficiency were first analyzed with Bartlett's test (1937) for data homogeneity (a level 0.001). When significant heterogeneity was detected, linear and power (log x,x 2 ,x~l) transformations of these data were sequentially performed in order to achieve data homogeneity, if possible, prior to one-way analysis of variance (ANOVA). The results of each round of power transformation were analyzed with Bartlett's test to determine if data homogeneity had been achieved. If the variances could not be stabilized with any of the above transformations, the data were ranked prior to ANOVA. Qualitative data, which include clinical observations, were analyzed by Fisher's exact test (Freeman and Halton, 1951) . The probability of Type I error (a) was set at 0.05 except for Bartlett's test. Statistical test results that reached the 0 01 level of significance were also noted. Statistical evaluation of survival and tumor data was performed using life table techniques (Thomas et al., 1977; Mantel, 1966) .
Differences in clinical laboratory parameters considered likely to be due to stock were distinguished from spurious differences by the following method. The data were examined for statistical difference, the number of intervals for which differences were observed, consistency of magnitude and direction of differences, and consistency between the sexes. adrenal glands, heart, and spleen were weighed for all rats terminated at 1 and 2 years. The following tissues from all study animals were collected and fixed in either 10% neutral buffered Formalin or 2.5% buffered glutaraldehyde: integumentary-inguinal skin (mammary area), inguinal mammary gland (females only); musculoskeletal-skeletal muscle (thigh), joint (tibial-femoral), bone (tibia-femur); respiratory-nasal passage, trachea, lungs; cardiovascular-heart, aorta (thoracic); hematopoietic-thymus, spleen, bone marrow (sternum), lymph node (mesenteric and mandibular); digestive-salivary gland (mandibular and parotid), esophagus, stomach, duodenum, jejunum, ileum, cecum, colon, rectum/anus, pancreas, liver; urogenital-kidneys, urinary bladder, testes, epididymides, prostate, seminal vesicles/coagulating glands, ovaries, vagina, cervix, uterus; endocrinepituitary gland, thyroid gland, parathyroid glands, adrenal glands; nervous-brain, spinal cord (cervical, thoracic, lumbar, and sacral) , sciatic nerve; special senses-eyes, Harderian glands; and gross lesions, tissue masses, and associated tissues.
Histological preparation and evaluation. Tissues to be examined were trimmed, embedded in paraffin blocks, sectioned at approximately 4-6 pirn, and stained widi hematoxylin and eosin. Bony specimens were decalcified in 10% formic acid prior to processing. Nonneoplastic microscopic tissue lesions were sometimes diagnosed as to area of involvement (focal, multifocal, or diffuse) and were graded as to degree of severity according to the following guidelinesGrade 1 • Minimal. Included histopathologic change that is inconspicuous or barely noticeable but so minor, small, or infrequent as to warrant no more than the least assignable degree of severity.
Grade 2: Mild. Included histopathologic change that is a noticeable but not prominent feature of the tissue.
Grade 3: Moderate. Included histopathologic change that is a prominent but not dominant feature of the tissue.
RESULTS

In-Life Observations
Statistically significant differences in survival existed between CD and SD male and female rats. Survival was good in both stocks of rats for the first 78 weeks of the study ( 49% in the respective CD and SD males (69% higher in the SD rats). In the males, this rapid decline in survival occurred 4 to 8 weeks sooner in the CD rats than in the SD rats. Once this decline in survival occurred, the survival curves for the two stocks of rats appeared parallel from approximately Weeks 84 to 104. In the females, survival began to drop precipitously at Week 76 in the CD rats and at Week 92 in the SD rats. At Week 104, survival rates in the CD and SD females were 44 and 63%, respectively (43% higher in the SD rats). The survival curves for the females appeared parallel from Weeks 92 through 104, which also indicated that the decline in survival occurred earlier for the CD rats.
Frequently observed (incidence 5*10 per group) clinical observations were similar in the CD and SD males. These included chromodacryorrhea, chromorhinorrhea, cloudy eye, dehydration, hair thinning (CD), generalized pallor, loose stool (SD), reduced activity, roughened coat (CD), and sneezing (CD). Frequently observed clinical observations were similar in the CD and SD females and included chromodacryorrhea, chromorhinorrhea, dehydration, hair thinning, generalized pallor, and reduced activity (CD). A significant difference in the number of clinically palpable masses (Table 1) in the CD vs the SD males after 2 years on study was observed in the axillary and pelvic regions. Significant differences in the distribution of animals with clinically palpable masses in CD and SD females were observed in the axillary and thorax regions. The total numbers of animals with clinically palpable masses were similar in (Table 2) . However, the total numbers of palpable masses (45 vs 34 for the respective CD and SD males, 104 vs 66 for the females), were higher in the CD rats (Table 1) . This increase was due to a higher number of CD rats exhibiting three or more masses. At the 1-year interim, all CD and SD rats had normal ophthalmoscopic examination results, with the exception of one male SD rat which had a mild corneal opacity (Table  3 ). Findings at the 2-year interval revealed abnormalities in both the CD and SD rats. These findings included corneal opacities, pale retina, lenticular opacities, pannus, and missing eyes (usually secondary to orbital plexus blood collection). The incidence of comeal opacities (with and without pannus) was higher in the SD males (88%, p =s 0.01) than in the CD males (46%). In contrast, the CD males (36%) and females (19%) had a higher incidence of lenticular opacities than the SD rats (0%, p =£ 0.01).
The CD male and female rats had statistically significantly {p =£ 0.01, all time points) greater body weights (CD males/ females were 26/26, 30/26, 38/52, and 48/59% heavier than corresponding SD rats at 4, 13, 52/53, and 104/105 weeks; (Fig. 2) ) than the respective SD male and female rats. The CD males steadily gained weight for the first 78 weeks of the study, whereas the rate of weight gain in the SD males decreased after the first 56 weeks of the study. The CD females rapidly gained weight for the first 78 weeks of the study, whereas body weight gain for the SD females was very gradual throughout the study.
The average food consumption curves (Fig. 3) (Fig. 4) was slightly higher in the SD rats. Compared to the SD rats, the CD rats tended to have higher mean water consumption values (Fig. 5) , especially during the first 30 weeks of the study in the males and during the first 22 weeks in the females. For the remainder of the study, water consumption values were usually higher in the CD animals with the exception of Weeks 74 through 94, during which water consumption values were higher in the SD males.
Hematology parameters (Table 4) considered to be different for the CD and SD rats included WBC (consistently lower in the SD rats); RBC (somewhat lower in the SD rats); PLT (consistently lower in the SD rats); MCV, MCH, and MCHC (generally higher in the SD rats); and percentage of eosinophils (EOS) (consistently higher in the SD rats). HCT, HGB, and PT were similar in both stocks.
Differences in clinical chemistry parameters (Table 5 , ALT, AST, SDH, GGT, A/G, sodium, potassium, calcium, PHOS, and CK were similar in both stocks) considered likely to be due to stock included serum levels of glucose (somewhat lower levels in the SD females), BUN (consistently higher in the SD rats), total protein (somewhat lower in the SD rats), albumin (somewhat lower in the SD rats), cholesterol (consistently increased in the SD males), triglycerides (consistently decreased 50 ± 2 55 ± 1** 53 ± 2 54 ± 1** 16.9 ± 0.6 18.2 ± 0.5** 18.0 ± 0.6 18.8 ± 0.5** 34.1 ± 0.5 33.0 ± 0.5** 33.8 ± 0.4 34.5 ± 0.6** 1 ± 1 1 ± 1 1 ± 1 2 ± 1** 06 13.3 ± 2.3 8.6 ± 1.4** 9.3 ± 2.1 6.0 ± 1.0** in the SD females), ALK PHOS (consistently increased in the SD females), 5' NUCLEO (consistently decreased in the SD females), globulin (somewhat decreased in the SD males and consistently decreased in the SD females), and chloride (consistently higher in the SD females).
Over the course of the study, urine volumes were fairly consistent for a given stock and sex (Table 6A ) except for the SD males at 24 months, which had an increased urine volume relative to the earlier sample times. In comparisons of the CD and SD stocks, urine volumes were consistently lower in the SD rats with the exception of the 24-month male values, which were similar for both CD and SD rats. In both stocks of rats there was an age-related increase in urine protein; however, the SD rats tended to have higher urine protein scores (Table 6B) . Glucose, ketones, occult blood, urobilinogen, bilirubin, and microscopic evaluation of sediment results were similar for both stocks.
Postmortem Observations
As expected, absolute organ weights of the SD rats were generally lower than those seen in the CD rats (Table 7) . In males, statistically significant differences in absolute organ weights included brain (1 and 2 years), kidneys (1 year), and liver (1 year). Significant differences in the weights of adrenal glands, brain, heart, kidneys, liver, and ovaries (1 year only) were observed in the females at 1 and 2 years. ± 11 ± 9 ± 12 ± 10*' ± 2 ± 3* ± 2 ± 2** ± 0.1 ± 0.1 ± 0 1 ± 0.1" ± 0.2 ± 0.3* ± 0.3 ± 0 2" ± 0.1 ±01* ± 0.3 ± 0.2" ± 0.2 ± 0.3* ± 0.3 ± 0.1" ± 0.1 ± 0.0* ± 0.0 ± 0 3" ± 19 ± 14 ± 44 ± 22 ± 36 ± 15* ± 56
•+• 9** ± 38 ± 23 ± 18 ± 20" ± 2 ± 1 ± 7 ± 2** ± 2 ± 2" ± 2 ± 1" 118 ± 115 ± 116 ± 110 ± 13 ± 17 ± 12 ± 17 ± 08 ± 0.8 ± 0.8 ± 1 0 ± 7.8 ± 7.1 ± 7.9 ± 6.9 ± 3.7 ± 3.4 ± 4.5 ± 4.0 ± 4.1 ± 3.7 ± 3-5 ± 3.0 ± For the CD and SD males, notable differences in the percentage incidence (CD vs SD) of necropsy findings (all animals, data not shown) included general discoloration of the body (12 vs 25%), skin masses (37 vs 23%), mammary gland cysts (10 vs 3%), general discoloration of the mandibular lymph nodes (20 vs 3%), foci of discoloration in the liver (50 vs 10%), kidney cysts (12 vs 45%), rough pitted surface of the kidney (0 vs 28%), flaccid (5 vs 12%) and small (3 vs 13%) testes, enlargement (30 vs 5%) and general discoloration (12 vs 0%) of the pituitary gland, compression of the brain (25 vs 0%), and opaque or cloudy eyes (17 vs 27%).
For the CD and SD females, notable differences in the percentage incidence of necropsy findings included mam- Afore.Semiquantitative. N, Neg; TR, trace (<30); 1,1+ (30-100); 2, 2 + (100-300); 3, 3+ (>300 mg/dl). mary gland cysts (37 vs 25%) and hypertrophy (52 vs 33%), foci of discoloration in the lungs (7 vs 33%), general discoloration of the mandibular lymph nodes (10 vs 3%), enlargement of the axillary lymph nodes (18 vs 7%), foci of discoloration in the liver (50 vs 10%), abnormal contents (red fluid) of the uterus (0 vs 8%), enlargement (63 vs 27%) and general discoloration (43 vs 17%) of the pituitary gland, enlargement of the adrenal glands (18 vs 5%), compression of the brain (43 vs 20%), and opaque or cloudy eyes (8 vs 2%).
There were a number of differences in the incidence and/ or severity of nonneoplastic (Table 8 ) and neoplastic (Table  9 ) lesions in the CD and SD rats. Some of these differences were observed consistently in both sexes for a given stock, thus strengthening the probability that they were attributable to stock difference. In the SD rats, adrenal gland findings of pheochromocytoma, ectopic adrenal, and hyperplasia of the medulla were increased in both sexes. Thyroid gland parafollicular (C-cell) hyperplasia and adenoma were increased in the SD rat. Moreover, kidney disease was more prevalent in both sexes of the SD rats. Progressive nephropathy was a frequent cause of death in the males (Table 10) . Findings secondary to kidney pathology included increases in the incidence and/or severity of hyperplasia of the parathyroid glands, systemic arterial and gastric mineralization, and fibrous osteodystrophy.
Additional microscopic findings (Table 8) with an increase in incidence and/or severity in the SD rats included acinar atrophy of the mammary gland, atrophy of skeletal muscle, spinal cord degeneration and nerve root axonal degeneration (radiculoneuropathy), mineralization of the prostate gland, arrested testicular spermatogenesis and associated oligospermia of the epididymides and seminiferous tubular degeneration, uterine cystic endometrial hyperplasia, squamous metaplasia, and pigmentation. There was also a higher incidence of corneal inflammation and mineralization, which was in agreement with the ophthalmoscopic findings of increased incidence of corneal opacities seen in the SD rat. Microscopic findings in the CD rat were consistent with more rapid aging and associated with lower survival. A major cause of death in the CD rat (Table 10 ) was adenoma and carcinoma of the pituitary gland (nonpalpable tumor), which resulted in compression of the brain. The CD rats also had a higher incidence and/or severity of progressive cardiomyopathy, various hepatic findings, various pulmonary findings, pancreatic atrophy and stromal fatty infiltration, inflammation of the prostate gland, atrophy of the parotid salivary gland, and ulceration of the skin. In the CD females, there was an increased incidence of mammary gland tumors as well as ovarian Sertoli cell hyperplasia. Results of life table analysis on the mammary gland tumor onset time indicated a significant difference between the CD and SD rats for mammary gland fibroadenomas, with CD rats showing a decreased onset time.
The total numbers of animals with neoplasms were similar in the CD and SD rats (Table 11) . However, the total number of neoplasms (114 vs 91 for males and 140 vs 129 for females) was higher in the CD than in the SD rats.
DISCUSSION
The many observed differences between the CD and SD rats could have resulted from genetic and/or environmental factors. In this experiment, we carefully controlled the environmental factors (e.g., temperature, humidity, diet, drinking water, cage size, food availability, animal handling) and thereby eliminated them as possible causes. Thus, the differences between these stocks were most likely due to inherent genetic differences in factors such as appetite, growth potential, hormonal regulation, and metabolic rate. Since food intake/kg body wt was slightly higher in the SD rats, it is possible that the metabolic rate was higher in the SD rat and/or that the SD rat was less efficient in food digestion.
It cannot be determined from the present study whether the increased survival and decreased incidence of total palpable masses and neoplasms observed in the SD rats were related to their lower food consumption and body weight. Other investigators have demonstrated improved survival and overall health and lower serum cholesterol, triglyceride, and glucose levels when CD rats were placed on calorically restricted diets (Goldstein, 1990; Keenan et ai, 1994) . In the studies conducted by Keenan et al. (1994) , the overall incidences of benign and malignant neoplasia were similar in ad libitum fed and feed-restricted rats. The ad libitum fed " Data are summarized for all animals (found dead, unscheduled deaths, and 1-and 2-year termination). Only nonneoplastic findings with an increased incidence in one stock compared to the other stock are included. Determination of stock-related differences in the incidence and/or severity of nonneoplastic histological lesions was made by visual and statistical inspection of the summary data for all animals. Following this comparison, the male and female data were compared for congruency. If a finding was present in both sexes and the magnitude or direction (increase or decrease in CD vs SD or vice versa) of that finding was similar in both sexes, it was also indicated.
* rats tended to have an earlier onset and larger neoplasms. In addition, the ad libitum fed rats had a higher incidence and severity of renal and cardiovascular disease. In our study, the findings of increased survival, lower body weight gain and food consumption, lower triglyceride levels, similar numbers of animals with neoplasms and palpable masses, longer onset time for mammary gland fibroadenomas, and better overall health in the SD rat were consistent with those reported for the feed-restricted CD rats and support the notion that rats with lower food consumption and body weight gain would have better longevity. However, our finding of higher total serum cholesterol values in the SD than in the CD males did not correlate with mortality rates in the SD rats.
The higher total number of palpable masses and neoplasms seen in the CD rat is probably related to its more rapid aging and/or a different hormonal homeostasis. It is possible that a similar total number of palpable masses and neoplasms would have been observed if the SD rats were allowed to live until a level of survival equivalent to that seen in the CD rats at termination was reached.
The higher incidence and/or severity of renal disease in the SD rats was surprising in light of the better survival seen in these rats. Within each stock, renal disease also tended to be more severe in males than in females and the severity increased with age. For the SD rats, this renal disease was characterized by increased urinary protein, by increased 
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Data are summarized for all animals (found dead, unscheduled deaths, and 1-and 2-year termination). Only neoplastic findings with an increased incidence in one stock compared to the other stock or with an incidence » 10% are included. Determination of stock-related differences in the incidence of neoplastic histological lesions was made by visual and statistical inspection of the summary data for all animals. Following this comparison, the male and female data were compared for congruency. If a finding was present in both sexes and the magnitude or direction (increase or decrease in CD vs SD or vice versa) or that finding was similar in both sexes, it was also indicated.
* [Number of animals examined].
• Significantly different, p «; 0.05. *• Significantly different, p « 0.01. BUN and creatinine levels, and by increased incidence and/ or severity of progressive nephropathy, which was a frequent cause of death in the males. Other findings consistent with more severe kidney disease in the SD rats included an increase in urine volume at 24 months and higher water consumption values during the latter part of the study. An increased prevalence of findings secondary to kidney pathology (hyperplasia of the parathyroid glands, systemic arterial and gastric mineralization, and fibrous osteodystrophy) was also observed in the SD rat. This increased propensity for spontaneous renal disease may limit the utility of the SD rat for studying nephrotoxic compounds. A low-protein diet may reduce the incidence and/or severity of renal disease (Goldstein, 1990) .
The increased incidence of pheochromocytoma and adrenal medullary hyperplasia in the SD rat are believed to be related. The increases in thyroid gland parafollicular (C-cell) cell hyperplasia and adenoma in the SD rat are also believed to be related. Within each stock, these adrenal and thyroid gland findings occurred at a higher incidence in the females.
The higher serum ALK PHOS levels seen in the SD females were not accompanied by discernable differences in functional biliary obstruction. Rather, these levels merely reflected the normal levels for this enzyme in this stock of rat. Consistent with this interpretation was the finding that another marker for potential cholestasis, 5' NUCLEO activity, was lower in the SD females.
Both the CD rat and the SD rat are maintained as outbred stocks (Haseman, 1989) . Therefore, it is not surprising that differences between the stocks have evolved over the past several decades. Stock differences also resulted from differences in breeding practices employed in the production of these stocks of rats. We believe that the increased growth rate, predisposition toward obesity, shortened life span, and decreased incidence of testicular findings in the CD rat re- Data are summarized for all animals (found dead, unscheduled deaths, and 1-and 2-year termination).
• Significantly different, p *; 0.05. ** Significantly different, p a; 0.01.
suited from selecting rats for rapid growth rate and increased fecundity.
Since the CD and SD rats share a common lineage, it was logical to compare these rats for characteristics that would make one a better model for chronic toxicity and oncogenicity studies. In this study, the SD rat exhibited several characteristics which make it a better model for chronic toxicity and oncogenicity bioassays. These include better survival, which is important in the determination of the oncogenic potential of chemicals and in the characterization of the chronic toxicity of chemicals. Improved survival increases the statistical power of a bioassay and reduces age-associated pathology, thus improving the ability to discriminate background findings from chemically induced effects. Moreover, with better survival more rats would be exposed to the test chemical for a longer period of time, which would increase the likelihood of observing treatment-related toxicity (Hart et al., 1995) . Since it takes less time to necropsy and microscopically evaluate rats of relatively good health than it does to evaluate rats that are found dead or killed in extremis, the cost of conducting a bioassay with the SD rat may be reduced, as would the time needed to complete the final report. This may help decrease the time and cost needed to obtain regulatory approval for a new chemical and thereby increase its profitability. The smaller size of the SD rat is also advantageous since smaller rats are easier to handle and house, consume less food, and produce less waste. Chemical usage needs are also considerably reduced in a smaller rat, which is advantageous in testing very expensive chemicals and/or those of limited availability. Overall, the background tumor incidence we observed in the CD rat was similar to that reported by McMartin et al. (1992) . The background tumor incidence of the SD rat has not been previously reported. In selecting an animal model for carcinogenicity bioassay, it is important to have a reasonable background level of tumors so that die agent being tested can interact with spontaneous processes and the background tumor incidence is not so high as to confound the interpretation of the results (Hart et al., 1995) . In this study, the background tumor incidence in the SD rat was at a level which allows assessment of oncogenic potential of chemical agents.
The major disadvantage of switching to the SD rat is that experience and historical control data in this stock of rat are not as widely available. However, this apparent disadvantage is inconsequential when one considers that survival, fecundity, body weight, and food consumption have changed in the CD rat over the recent past. This limits the value of historical control data which are more than a few years old.
Taken together, the better survival, smaller size, and lower food consumption of the SD rat may make it a better model than CD rats for long-term chronic toxicity/oncogenicity studies. However, the increased propensity for spontaneous renal disease may limit the utility of the SD rat for studying nephrotoxic compounds.
